Sale!

Nx Gen Sequencing Dystonia Test Cost

Original price was: 5,200 د.إ.Current price is: 4,680 د.إ.

-10%

The “Nx Gen Sequencing Dystonia Test” is a cutting-edge diagnostic tool available at DNA Labs UAE, specifically designed to identify genetic mutations associated with dystonia. Dystonia is a movement disorder characterized by involuntary muscle contractions, leading to repetitive movements or abnormal postures. This test leverages Next-Generation Sequencing (NGS) technology to meticulously analyze the genetic markers linked to various forms of dystonia, providing a comprehensive understanding of the genetic underpinnings of the disorder.

By examining a broad spectrum of genes simultaneously, the Nx Gen Sequencing Dystonia Test offers a highly accurate and efficient approach to diagnosing dystonia, enabling tailored treatment strategies based on the individual’s genetic profile. This personalized approach to diagnosis and treatment represents a significant advancement in the management of dystonia, offering hope to those affected by the condition.

The test is priced at 4680 AED and is conducted at DNA Labs UAE, a state-of-the-art facility renowned for its commitment to providing advanced genetic testing services. DNA Labs UAE employs a team of highly skilled professionals and utilizes the latest technology to ensure the highest standards of accuracy and reliability in genetic testing.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Nx GEN SEQUENCING DYSTONIA Test

Test Name: Nx GEN SEQUENCING DYSTONIA Test

Components: ADCY5, ANO3, ARSA, ATM, ATP1A3, ATP7B, CACNA1B, CIZ1, COL6A3, DRD2, GCDH, GCH1, GNAL, HPCA, KCNMA1, KCTD17, PANK2, PARK2, PLA2G6, PNKD, PRKRA, PRRT2, RELN, SGCE, SLC2A1, SLC6A3, SPR, TH, THAP1, TIMM8A, TOR1A, TUBB4A

Price: 4680.0 AED

Sample Condition: Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.

Report Delivery: Sample Daily by 9 am; Report 40 Working days

Method: NGS, Sanger sequencing

Test type: Genetic Disorders-Movement disorder

Doctor: Neurologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.

Test Details

Dystonia is a movement disorder characterized by involuntary muscle contractions that cause repetitive or twisting movements and abnormal postures. It can affect various parts of the body, including the neck, limbs, and trunk.

Dystonia can be inherited or acquired, and genetic testing can help identify the underlying cause of the condition. Nx Gen Sequencing is a next-generation sequencing technology that allows for the rapid and accurate analysis of genetic material. It can be used to sequence the entire genome or specific regions of interest, such as genes associated with dystonia.

The Dystonia Test using Nx Gen Sequencing involves obtaining a DNA sample from the individual being tested, typically through a blood or saliva sample. The DNA is then sequenced using Nx Gen Sequencing technology to identify any genetic variants or mutations that may be associated with dystonia.

By analyzing the genetic information, the test can provide valuable insights into the genetic basis of dystonia and help guide treatment decisions. It can identify specific gene mutations or variants that may be responsible for the condition, allowing for more personalized and targeted therapies.

In summary, the Nx Gen Sequencing: Dystonia Test is a genetic test that uses next-generation sequencing technology to analyze the DNA of individuals with dystonia. It can provide important information about the genetic basis of the condition and guide treatment decisions.

Test Name Nx GEN SEQUENCING DYSTONIA Test
Components ADCY5, ANO3, ARSA, ATM, ATP1A3, ATP7B, CACNA1B, CIZ1, COL6A3, DRD2, GCDH, GCH1, GNAL, HPCA, KCNMA1, KCTD17, PANK2, PARK2, PLA2G6, PNKD, PRKRA, PRRT2, RELN, SGCE, SLC2A1, SLC6A3, SPR, TH, THAP1, TIMM8A, TOR1A, TUBB4A
Price 4680.0 AED
Sample Condition Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Report Delivery Sample Daily by 9 am; Report 40 Working days
Method NGS, Sanger sequencing
Test type Genetic Disorders-Movement disorder
Doctor Neurologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Test Details

Dystonia is a movement disorder characterized by involuntary muscle contractions that cause repetitive or twisting movements and abnormal postures. It can affect various parts of the body, including the neck, limbs, and trunk. Dystonia can be inherited or acquired, and genetic testing can help identify the underlying cause of the condition.

Nx Gen Sequencing is a next-generation sequencing technology that allows for the rapid and accurate analysis of genetic material. It can be used to sequence the entire genome or specific regions of interest, such as genes associated with dystonia.

The Dystonia Test using Nx Gen Sequencing involves obtaining a DNA sample from the individual being tested, typically through a blood or saliva sample. The DNA is then sequenced using Nx Gen Sequencing technology to identify any genetic variants or mutations that may be associated with dystonia.

By analyzing the genetic information, the test can provide valuable insights into the genetic basis of dystonia and help guide treatment decisions. It can identify specific gene mutations or variants that may be responsible for the condition, allowing for more personalized and targeted therapies.

In summary, the Nx Gen Sequencing: Dystonia Test is a genetic test that uses next-generation sequencing technology to analyze the DNA of individuals with dystonia. It can provide important information about the genetic basis of the condition and guide treatment decisions.